Log In
BCIQ
Print this Print this
 

Sumavel DosePro, sumatriptan

Also known as: formerly Intraject sumatriptan

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionSumatriptan injection delivered via the DosePro needle-free system
Molecular Target Serotonin (5-HT1) receptor
Mechanism of ActionSerotonin (5-HT1) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat acute migraine and cluster headaches; Treat migraine headache with or without aura
Regulatory Designation EU - Named Patient Program (Treat acute migraine and cluster headaches)
PartnerDesitin Arzneimittel GmbH;
Tzamal Medical Group Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$105.0M

$85.0M

$20.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today